布地奈德 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "布地奈德" in Chinese language version.

refsWebsite

Global rank Chinese rank

50web.archive.org

1^st place

22nih.gov

4^th place

5^th place

17doi.org

2^nd place

23^rd place

8lexi.com

low place

5drugs.com

399^th place

208^th place

5books.google.com

3^rd place

8^th place

5europa.eu

68^th place

209^th place

4semanticscholar.org

11^th place

332^nd place

2archive.org

6^th place

4^th place

2fda.gov

447^th place

581^st place

2clincalc.com

3,912^th place

5,917^th place

2emedicinehealth.com

8,799^th place

8,157^th place

2worldcat.org

5^th place

12^th place

2drugbank.com

low place

2mhra.gov.uk

low place

1hres.ca

low place

1handle.net

102^nd place

492^nd place

1ginasthma.org

low place

1mayoclinic.org

1,610^th place

2,275^th place

1sciencedirect.com

149^th place

292^nd place

1nytimes.com

7^th place

31^st place

1justice.gov

918^th place

1,784^th place

1bbc.co.uk

8^th place

32^nd place

1thetimes.co.uk

170^th place

721^st place

1nihr.ac.uk

low place

1newindianexpress.com

188^th place

5,003^rd place

1mohfw.gov.in

low place

1pharmaceutical-journal.com

low place

archive.org

Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168 .

bbc.co.uk

Roxby P. Covid: Asthma drug 'speeds up recovery at home'. BBC News. 12 April 2021 [2021-04-12]. （原始内容存档于12 April 2021）.

books.google.com

Domeij B. Pharmaceutical patents in Europe. The Hague: Kluwer Law International. 2000: 278. ISBN 9789041113481. （原始内容存档于2015-12-08）.
Hamley P. Small Molecule Medicinal Chemistry: Strategies and Technologies. John Wiley & Sons. 2015: 390. ISBN 9781118771693. （原始内容存档于2015-12-08）.
Baily DG. Grapefruit and Other Fruit Juices Interactions with Medicines. Boullata JI, Armenti VT (编). Handbook of drug-nutrient interactions 2nd. New York, NY: Humana Press. 2010: 282 [2024-05-29]. ISBN 978-1-60327-362-6. （原始内容存档于2024-04-30）.
Kizior RJ, Hodgson BB. Saunders Nursing Drug Handbook 2019 E-Book. Elsevier Health Sciences. 2018-02-21: 160 [2020-10-05]. ISBN 978-0-323-61257-9. （原始内容存档于2024-04-30）.
Skidmore-Roth L, Richardson F. Mosby's Canadian Nursing Drug Reference - E-Book. Elsevier Health Sciences. 9 July 2020: 187 [2020-10-05]. ISBN 978-1-77172-084-7. （原始内容存档于2024-03-11）.

clincalc.com

The Top 300 of 2021. ClinCalc. [2024-01-14]. （原始内容存档于2024-01-15）.
Budesonide - Drug Usage Statistics. ClinCalc. [2024 -01-14]. （原始内容存档于2017-04-29）.

doi.org

De Coster DA, Jones M. Tailoring of corticosteroids in COPD management. Current Respiratory Care Reports. 2014, 3 (3): 121–132. PMC 4113685 . PMID 25089228. doi:10.1007/s13665-014-0084-2.
Christophi GP, Rengarajan A, Ciorba MA. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clinical and Experimental Gastroenterology. 2016, 9: 125–30. PMC 4876845 . PMID 27274301. doi:10.2147/CEG.S80237 .
Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
Silverman J, Otley A. Budesonide in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology. July 2011, 7 (4): 419–28. PMID 21790284. S2CID 32892611. doi:10.1586/eci.11.34.
Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis. Gastroenterology. January 2016, 150 (1): 247–274.e11. PMID 26584602. doi:10.1053/j.gastro.2015.11.006.
Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168 .
Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, et al. Budesonide for maintenance of remission in Crohn's disease.. Cochrane Database Syst Rev. 2014, 8 (8): CD002913. PMC 7133546 . PMID 25141071. doi:10.1002/14651858.CD002913.pub3.
Habal FM, Huang VW. Review Article: A Decision-Making Algorithm For the Management of Pregnancy in the Inflammatory Bowel Disease Patient. Aliment Pharmacol Ther. 2012, 35 (5): 501–15. PMID 22221203. S2CID 34662981. doi:10.1111/j.1365-2036.2011.04967.x .
Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis. Gastroenterology. January 2016, 150 (1): 247–274.e11. PMID 26584602. doi:10.1053/j.gastro.2015.11.006.
Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn AM, Wildt S, Bohr J, Bonderup O, Bouma G, D'Amato M, Heiberg Engel PJ, Fernandez-Banares F, Macaigne G, Hjortswang H, Hultgren-Hörnquist E, Koulaouzidis A, Kupcinskas J, Landolfi S, Latella G, Lucendo A, Lyutakov I, Madisch A, Magro F, Marlicz W, Mihaly E, Munck LK, Ostvik AE, Patai ÁV, Penchev P, Skonieczna-Żydecka K, Verhaegh B, Münch A. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterology Journal. February 2021, 9 (1): 13–37. PMC 8259259 . PMID 33619914. doi:10.1177/2050640620951905.
Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clinical Therapeutics. April 2004, 26 (4): 473–92. PMID 15189745. doi:10.1016/s0149-2918(04)90050-1.
Rawla P, Sunkara T, Thandra KC, Gaduputi V. Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies. Drugs in R&D. December 2018, 18 (4): 259–269. PMC 6277325 . PMID 30387081. doi:10.1007/s40268-018-0253-9.
Todd, G R G. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Archives of Disease in Childhood. 2002-12-01, 87 (6): 457–461. PMC 1755820 . PMID 12456538. doi:10.1136/adc.87.6.457.
Todd GR, Acerini CL, Buck JJ, Murphy NP, Ross-Russell R, Warner JT, McCance DR. Acute Adrenal Crisis in Asthmatics Treated With High-Dose Fluticasone Propionate. Eur Respir J. 2002, 19 (6): 1207–9. PMID 12108877. doi:10.1183/09031936.02.00274402 .
Ajimura, Chanelle M.; Jagan, Nikhil; Morrow, Lee E.; Malesker, Mark A. Drug Interactions With Oral Inhaled Medications. Journal of Pharmacy Technology. December 2018, 34 (6): 273–280. ISSN 8755-1225. PMC 6231282 . PMID 34861014. doi:10.1177/8755122518788809 （英语）.
Platform trial rules out treatments for COVID-19. NIHR Evidence (Plain English summary). 2022 -05-31 [1 June 2022]. doi:10.3310/nihrevidence_50873. （原始内容存档于2022-06-01）. 请检查|date=中的日期值 (帮助)
Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, Van Hecke O, Ogburn E, Evans PH, Thomas NP, Patel MG, Richards D, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Shanyinde M, de Lusignan S, Andersson MI, Barnes PJ, Russell RE, Nicolau DV, Ramakrishnan S, Hobbs FD, Butler CC. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. September 2021, 398 (10303): 843–855. PMC 8354567 . PMID 34388395. doi:10.1016/S0140-6736(21)01744-X.

drugbank.com

go.drugbank.com

Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2024-07-07）（英语）.
Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2023-12-23）（英语）.

drugs.com

Budesonide. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-11-28）.
Budesonide eent. The American Society of Health-System Pharmacists. [2 December 2015]. （原始内容存档于2015-12-08）.
Budesonide. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-11-28）.
英国药物信息
Budesonide inhalation Uses, Side Effects & Warnings. Drugs.com. [2024-05-03]. （原始内容存档于2024-06-19）（英语）.

emedicinehealth.com

GENERIC NAME: BUDESONIDE - NASAL AEROSOL INHALER (byou-DESS-oh-nide). eMedicineHealth. （原始内容存档于2008-11-06）.
What are the possible side effects of budesonide nasal (Childrens Rhinocort Allergy, Rhinocort Allergy, Rhinocort Aqua)?. eMedicineHealth. [2020-08-25]. （原始内容存档于2020-08-06）.

europa.eu

ema.europa.eu

Jorveza EPAR. European Medicines Agency (EMA). 17 September 2018 [2023-03-03]. （原始内容存档于2023-03-04）.
Kinpeygo EPAR. European Medicines Agency (EMA). 2022-05-17 [2023-03-03]. （原始内容存档于2023-03-04）.
Budesonide: CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00000449/201604 (PDF). European Medicines Agency (EMA). 2017-03-10 [2017-05-19]. （原始内容存档 (PDF)于2017-09-08）.
Kinpeygo: Pending EC decision. European Medicines Agency (EMA). 20 May 2022 [2022-05-20]. （原始内容存档于2022-05-20）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

ec.europa.eu

Kinpeygo Product information. Union Register of medicinal products. [2023-03-03]. （原始内容存档于2023-03-04）.

fda.gov

First Generic Drug Approvals 2023. U.S. Food and Drug Administration (FDA). 2023-05-30 [30 June 2023]. （原始内容存档于30 June 2023）.
FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease. U.S. Food and Drug Administration (FDA). 2021-12-17 [2021-12-18]. （原始内容存档于2021-12-19）. 本文含有此來源中屬於公有领域的内容。

ginasthma.org

Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GiNA) 2011. Available at https://www.ginasthma.org 互联网档案馆的存檔，存档日期2013-10-14.

handle.net

hdl.handle.net

World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

hres.ca

hpr-rps.hres.ca

Regulatory Decision Summary - Uceris. Health Canada. 2014-10-23 [2022-06-04]. （原始内容存档于2022-06-05）.

justice.gov

Major Generic Drug Companies to Pay Over Quarter of a Billion Dollars to Resolve Price-Fixing Charges and Divest Key Drug at the Center of Their Conspiracy. DOJ. 2023-08-21 [2024-05-21]. （原始内容存档于2024-02-09）.

lexi.com

online.lexi.com

Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Systemic). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024 -04-28 [2024-05-29]. （原始内容存档于2024-07-18）. 请检查|date=中的日期值 (帮助)
Budesonide (Topical). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Systemic). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Nasal). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Topical). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.

mayoclinic.org

Budesonide (Oral Route) Precautions - Mayo Clinic. www.mayoclinic.org. [2024-05-03]. （原始内容存档于2024-05-03）.

mhra.gov.uk

cas.mhra.gov.uk

COVID-19 Therapeutic Alert - Inhaled Budesonide for Adults (50 Years and Over) with COVID-19. Central Alerting System. 2021-04-12 [16 April 2021]. （原始内容存档于2021-04-12）.
Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for COVID-19. Central Alerting System. [2022-05-20]. （原始内容存档于2022-06-30）.

mohfw.gov.in

Clinical Management Protocol for Covid-19 (in Adults) (PDF). Ministry of Health and Family Welfare (India). 2021-05-24 [2021-07-10]. （原始内容存档 (PDF)于2021-12-05）.

newindianexpress.com

New guidelines prescribe inhaled steroid 'Budesonide', antiparasitic drug 'Ivermectin' for mild Covid cases. The New Indian Express. 2021-04-29 [021-07-11]. （原始内容存档于2021-11-06）.

nih.gov

ncbi.nlm.nih.gov

De Coster DA, Jones M. Tailoring of corticosteroids in COPD management. Current Respiratory Care Reports. 2014, 3 (3): 121–132. PMC 4113685 . PMID 25089228. doi:10.1007/s13665-014-0084-2.
Christophi GP, Rengarajan A, Ciorba MA. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clinical and Experimental Gastroenterology. 2016, 9: 125–30. PMC 4876845 . PMID 27274301. doi:10.2147/CEG.S80237 .
Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
Silverman J, Otley A. Budesonide in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology. July 2011, 7 (4): 419–28. PMID 21790284. S2CID 32892611. doi:10.1586/eci.11.34.
Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis. Gastroenterology. January 2016, 150 (1): 247–274.e11. PMID 26584602. doi:10.1053/j.gastro.2015.11.006.
Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168 .
Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, et al. Budesonide for maintenance of remission in Crohn's disease.. Cochrane Database Syst Rev. 2014, 8 (8): CD002913. PMC 7133546 . PMID 25141071. doi:10.1002/14651858.CD002913.pub3.
Habal FM, Huang VW. Review Article: A Decision-Making Algorithm For the Management of Pregnancy in the Inflammatory Bowel Disease Patient. Aliment Pharmacol Ther. 2012, 35 (5): 501–15. PMID 22221203. S2CID 34662981. doi:10.1111/j.1365-2036.2011.04967.x .
Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis. Gastroenterology. January 2016, 150 (1): 247–274.e11. PMID 26584602. doi:10.1053/j.gastro.2015.11.006.
Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn AM, Wildt S, Bohr J, Bonderup O, Bouma G, D'Amato M, Heiberg Engel PJ, Fernandez-Banares F, Macaigne G, Hjortswang H, Hultgren-Hörnquist E, Koulaouzidis A, Kupcinskas J, Landolfi S, Latella G, Lucendo A, Lyutakov I, Madisch A, Magro F, Marlicz W, Mihaly E, Munck LK, Ostvik AE, Patai ÁV, Penchev P, Skonieczna-Żydecka K, Verhaegh B, Münch A. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterology Journal. February 2021, 9 (1): 13–37. PMC 8259259 . PMID 33619914. doi:10.1177/2050640620951905.
Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clinical Therapeutics. April 2004, 26 (4): 473–92. PMID 15189745. doi:10.1016/s0149-2918(04)90050-1.
Rawla P, Sunkara T, Thandra KC, Gaduputi V. Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies. Drugs in R&D. December 2018, 18 (4): 259–269. PMC 6277325 . PMID 30387081. doi:10.1007/s40268-018-0253-9.
Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
Todd, G R G. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Archives of Disease in Childhood. 2002-12-01, 87 (6): 457–461. PMC 1755820 . PMID 12456538. doi:10.1136/adc.87.6.457.
Todd GR, Acerini CL, Buck JJ, Murphy NP, Ross-Russell R, Warner JT, McCance DR. Acute Adrenal Crisis in Asthmatics Treated With High-Dose Fluticasone Propionate. Eur Respir J. 2002, 19 (6): 1207–9. PMID 12108877. doi:10.1183/09031936.02.00274402 .
Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
Ajimura, Chanelle M.; Jagan, Nikhil; Morrow, Lee E.; Malesker, Mark A. Drug Interactions With Oral Inhaled Medications. Journal of Pharmacy Technology. December 2018, 34 (6): 273–280. ISSN 8755-1225. PMC 6231282 . PMID 34861014. doi:10.1177/8755122518788809 （英语）.
Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, Van Hecke O, Ogburn E, Evans PH, Thomas NP, Patel MG, Richards D, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Shanyinde M, de Lusignan S, Andersson MI, Barnes PJ, Russell RE, Nicolau DV, Ramakrishnan S, Hobbs FD, Butler CC. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. September 2021, 398 (10303): 843–855. PMC 8354567 . PMID 34388395. doi:10.1016/S0140-6736(21)01744-X.

dailymed.nlm.nih.gov

Tarpeyo- budesonide capsule, delayed release. DailyMed. [2021-12-24]. （原始内容存档于2021-12-25）.
Pulmicort Flexhaler- budesonide aerosol, powder. DailyMed. [2021-12-24]. （原始内容存档于2021-09-19）.
Eohilia- budesonide suspension. DailyMed. 2024-02-09 [2024-02-26]. （原始内容存档于2024-02-26）.

nihr.ac.uk

evidence.nihr.ac.uk

Platform trial rules out treatments for COVID-19. NIHR Evidence (Plain English summary). 2022 -05-31 [1 June 2022]. doi:10.3310/nihrevidence_50873. （原始内容存档于2022-06-01）. 请检查|date=中的日期值 (帮助)

nytimes.com

Murphy H. Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say. The New York Times. 2019-05-11 [2020-05-27]. （原始内容存档于2020-05-30）.

pharmaceutical-journal.com

Burns C. NICE removes budesonide from recommended COVID-19 treatments. The Pharmaceutical Journal. 2021-12-15 [2022-06-01]. （原始内容存档于2022-06-26）.

sciencedirect.com

Gavins, Felicity; Flower, Roderick J., Enna, S. J.; Bylund, David B. , 编, Budesonide, xPharm: The Comprehensive Pharmacology Reference (New York: Elsevier), 2008-01-01: 1–5 [2024-05-03], ISBN 978-0-08-055232-3, （原始内容存档于2022-07-22）

semanticscholar.org

api.semanticscholar.org

Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. The Laryngoscope. July 2012, 122 (7): 1431–7. PMID 22410935. S2CID 25637461. doi:10.1002/lary.23259.
Silverman J, Otley A. Budesonide in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology. July 2011, 7 (4): 419–28. PMID 21790284. S2CID 32892611. doi:10.1586/eci.11.34.
Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's Disease in Adults. Am J Gastroenterol. 2009, 104 (2): 465–83. PMID 19174807. S2CID 10176441. doi:10.1038/ajg.2008.168 .
Habal FM, Huang VW. Review Article: A Decision-Making Algorithm For the Management of Pregnancy in the Inflammatory Bowel Disease Patient. Aliment Pharmacol Ther. 2012, 35 (5): 501–15. PMID 22221203. S2CID 34662981. doi:10.1111/j.1365-2036.2011.04967.x .

thetimes.co.uk

Blakely R. Asthma drug Budesonide speeds up Covid recovery times. The Times. 2021-04-12 [2021-04-13]. ISSN 0140-0460. （原始内容存档于202-11-06）.

web.archive.org

Regulatory Decision Summary - Uceris. Health Canada. 2014-10-23 [2022-06-04]. （原始内容存档于2022-06-05）.
Tarpeyo- budesonide capsule, delayed release. DailyMed. [2021-12-24]. （原始内容存档于2021-12-25）.
Pulmicort Flexhaler- budesonide aerosol, powder. DailyMed. [2021-12-24]. （原始内容存档于2021-09-19）.
Eohilia- budesonide suspension. DailyMed. 2024-02-09 [2024-02-26]. （原始内容存档于2024-02-26）.
Jorveza EPAR. European Medicines Agency (EMA). 17 September 2018 [2023-03-03]. （原始内容存档于2023-03-04）.
Kinpeygo EPAR. European Medicines Agency (EMA). 2022-05-17 [2023-03-03]. （原始内容存档于2023-03-04）.
Budesonide. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-11-28）.
Budesonide eent. The American Society of Health-System Pharmacists. [2 December 2015]. （原始内容存档于2015-12-08）.
Budesonide. The American Society of Health-System Pharmacists. [2015-12-02]. （原始内容存档于2015-11-28）.
Domeij B. Pharmaceutical patents in Europe. The Hague: Kluwer Law International. 2000: 278. ISBN 9789041113481. （原始内容存档于2015-12-08）.
Hamley P. Small Molecule Medicinal Chemistry: Strategies and Technologies. John Wiley & Sons. 2015: 390. ISBN 9781118771693. （原始内容存档于2015-12-08）.
First Generic Drug Approvals 2023. U.S. Food and Drug Administration (FDA). 2023-05-30 [30 June 2023]. （原始内容存档于30 June 2023）.
The Top 300 of 2021. ClinCalc. [2024-01-14]. （原始内容存档于2024-01-15）.
Budesonide - Drug Usage Statistics. ClinCalc. [2024 -01-14]. （原始内容存档于2017-04-29）.
Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GiNA) 2011. Available at https://www.ginasthma.org 互联网档案馆的存檔，存档日期2013-10-14.
FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease. U.S. Food and Drug Administration (FDA). 2021-12-17 [2021-12-18]. （原始内容存档于2021-12-19）. 本文含有此來源中屬於公有领域的内容。
GENERIC NAME: BUDESONIDE - NASAL AEROSOL INHALER (byou-DESS-oh-nide). eMedicineHealth. （原始内容存档于2008-11-06）.
What are the possible side effects of budesonide nasal (Childrens Rhinocort Allergy, Rhinocort Allergy, Rhinocort Aqua)?. eMedicineHealth. [2020-08-25]. （原始内容存档于2020-08-06）.
Budesonide: CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00000449/201604 (PDF). European Medicines Agency (EMA). 2017-03-10 [2017-05-19]. （原始内容存档 (PDF)于2017-09-08）.
Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
Budesonide (Oral Route) Precautions - Mayo Clinic. www.mayoclinic.org. [2024-05-03]. （原始内容存档于2024-05-03）.
Budesonide inhalation Uses, Side Effects & Warnings. Drugs.com. [2024-05-03]. （原始内容存档于2024-06-19）（英语）.
Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
Kalola, Urvashi K.; Ambati, Shashikanth, Budesonide, StatPearls (Treasure Island (FL): StatPearls Publishing), 2024 [2024-04-28], PMID 33085348, （原始内容存档于2024-03-30）
Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Baily DG. Grapefruit and Other Fruit Juices Interactions with Medicines. Boullata JI, Armenti VT (编). Handbook of drug-nutrient interactions 2nd. New York, NY: Humana Press. 2010: 282 [2024-05-29]. ISBN 978-1-60327-362-6. （原始内容存档于2024-04-30）.
Kizior RJ, Hodgson BB. Saunders Nursing Drug Handbook 2019 E-Book. Elsevier Health Sciences. 2018-02-21: 160 [2020-10-05]. ISBN 978-0-323-61257-9. （原始内容存档于2024-04-30）.
Skidmore-Roth L, Richardson F. Mosby's Canadian Nursing Drug Reference - E-Book. Elsevier Health Sciences. 9 July 2020: 187 [2020-10-05]. ISBN 978-1-77172-084-7. （原始内容存档于2024-03-11）.
Gavins, Felicity; Flower, Roderick J., Enna, S. J.; Bylund, David B. , 编, Budesonide, xPharm: The Comprehensive Pharmacology Reference (New York: Elsevier), 2008-01-01: 1–5 [2024-05-03], ISBN 978-0-08-055232-3, （原始内容存档于2022-07-22）
Budesonide (Systemic). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2024-07-07）（英语）.
Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024 -04-28 [2024-05-29]. （原始内容存档于2024-07-18）. 请检查|date=中的日期值 (帮助)
Budesonide (Topical). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Oral Inhalation). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide. go.drugbank.com. [2024-04-28]. （原始内容存档于2023-12-23）（英语）.
Budesonide (Systemic). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Nasal). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Budesonide (Topical). Lexi-Drugs. UpToDate Lexidrug. UpToDate Inc. 2024-04-28 [2024-05-29]. （原始内容存档于2024-07-18）.
Murphy H. Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say. The New York Times. 2019-05-11 [2020-05-27]. （原始内容存档于2020-05-30）.
Major Generic Drug Companies to Pay Over Quarter of a Billion Dollars to Resolve Price-Fixing Charges and Divest Key Drug at the Center of Their Conspiracy. DOJ. 2023-08-21 [2024-05-21]. （原始内容存档于2024-02-09）.
Kinpeygo: Pending EC decision. European Medicines Agency (EMA). 20 May 2022 [2022-05-20]. （原始内容存档于2022-05-20）. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
Kinpeygo Product information. Union Register of medicinal products. [2023-03-03]. （原始内容存档于2023-03-04）.
COVID-19 Therapeutic Alert - Inhaled Budesonide for Adults (50 Years and Over) with COVID-19. Central Alerting System. 2021-04-12 [16 April 2021]. （原始内容存档于2021-04-12）.
Roxby P. Covid: Asthma drug 'speeds up recovery at home'. BBC News. 12 April 2021 [2021-04-12]. （原始内容存档于12 April 2021）.
Blakely R. Asthma drug Budesonide speeds up Covid recovery times. The Times. 2021-04-12 [2021-04-13]. ISSN 0140-0460. （原始内容存档于202-11-06）.
Platform trial rules out treatments for COVID-19. NIHR Evidence (Plain English summary). 2022 -05-31 [1 June 2022]. doi:10.3310/nihrevidence_50873. （原始内容存档于2022-06-01）. 请检查|date=中的日期值 (帮助)
New guidelines prescribe inhaled steroid 'Budesonide', antiparasitic drug 'Ivermectin' for mild Covid cases. The New Indian Express. 2021-04-29 [021-07-11]. （原始内容存档于2021-11-06）.
Clinical Management Protocol for Covid-19 (in Adults) (PDF). Ministry of Health and Family Welfare (India). 2021-05-24 [2021-07-10]. （原始内容存档 (PDF)于2021-12-05）.
Burns C. NICE removes budesonide from recommended COVID-19 treatments. The Pharmaceutical Journal. 2021-12-15 [2022-06-01]. （原始内容存档于2022-06-26）.
Withdrawal of the Recommendation for Consideration of Inhaled Budesonide as a Treatment Option for COVID-19. Central Alerting System. [2022-05-20]. （原始内容存档于2022-06-30）.

worldcat.org

Ajimura, Chanelle M.; Jagan, Nikhil; Morrow, Lee E.; Malesker, Mark A. Drug Interactions With Oral Inhaled Medications. Journal of Pharmacy Technology. December 2018, 34 (6): 273–280. ISSN 8755-1225. PMC 6231282 . PMID 34861014. doi:10.1177/8755122518788809 （英语）.
Blakely R. Asthma drug Budesonide speeds up Covid recovery times. The Times. 2021-04-12 [2021-04-13]. ISSN 0140-0460. （原始内容存档于202-11-06）.